Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
Status:
Withdrawn
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
To evaluate whether there is a difference in symptomatic thromboembolism events in the subset
of patients with a history of, or risk factors for thromboembolic disease for topically
applied tranexamic acid in total joint arthroplasty.
Phase:
Phase 4
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University